FindTrial
Sign In

COMPARISON BETWEEN NALBUPHINE AND BUTORPHANOL FOR INTRAOPERATIVE AND POSTOPERATIVE ANALGESIA

COMPARISON Evaluation of NALBUPHINE HYDROCHLORIDE AND BUTORPHANOL TARTRATE FOR INTRAOPERATIVE AND POSTOPERATIVE ANALGESIA

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/01/003332
Enrollment
60
Registered
2013-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients posted for elective major surgery under general anesthesia

Interventions

Control Intervention1: NALBUPHINE HYDROCHLORIDE: 10 mg / 70 kg body wt, intravenously, given in premedication and then for postoperative analgesia upto 24 hours. Control Intervention2: Butorphanol Ta

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II patients either sex 20-60 years of age posted for elective major surgery under general anesthesia (GA)

Exclusion criteria

Exclusion criteria: Patients of COPD, known allergy to opioids, raised ICP, hepatobiliary/renal disease, psychiatric illness and un-cooperative patients were excluded from the study

Design outcomes

Primary

MeasureTime frame
Both the drugs were equally effective in providing intraoperative and postoperative analgesia.Timepoint: p more than 0.05—

Secondary

MeasureTime frame
sedation score between the two groups was statistically not significant indicating awake and pain free patients in both the groups.Timepoint: group N was 0.8 ± 0.76 and in group B it was 0.6 ± 0.0.72—

Countries

India

Contacts

Public ContactDr Pramod Velankar

Pad. Dr. D.Y. Patil medical college, pimpri, Pune

drmohdirfanpathan@gmail.com8007367036

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026